|Day Low/High||16.62 / 16.80|
|52 Wk Low/High||14.61 / 28.17|
U.S. District Judge Vince Chhabria said that he would have a final ruling by the end of next week.
Bayer shares traded near the top of the European market Thursday after activist investor Elliot Advisors revealed a $1.1 billion stake in the chemicals group and supported plans to boost its legal team in the face of thousands of Roundup weedkiller lawsuits.
Stocks shook off Monday's bruising U.S.-China trade war selloff to end in positive territory.
U.S. equity futures rebounded from the second-worst trading day of the year Tuesday, setting up a positive open on Wall Street as President Donald Trump insisted he was in a "fantastic position" in his escalating trade dispute with China.
U.S. stock futures point to a modest rebound for Wall Street on Tuesday after markets reeled in the previous session as China retaliated in its trade war with the U.S.; Bayer's Monsanto loses $2 billion verdict in Roundup cancer trial; Walmart takes on Amazon with free, next-day delivery.
Bayer shares traded sharply lower Tuesday after a jury in California awarded more than $2 billion to a pair of plaintiffs who said the chemicals group's Roundup weed killer caused them to contract cancer.
California verdict is the third against the company in less than a year.
Global stocks pared gains Thursday, as weakening data and dovish central bank actions added to concerns over the pace of world growth and offset the bullish tenor from last night's after-the-bell earnings on Wall Street.
U.S. stock futures are higher amid progress in U.S.-China trade talks; Five Below rises despite first-quarter guidance below estimates; Lyft jacks up its expected IPO price range; Lululemon soars after a strong earnings beat.
Verdict is second recent legal defeat for company that bought Monsanto last year.
Bayer, Janssen agreement ends four-year legal fight
U.S. stock futures turn lower as investors await a key decision on interest rates from the Federal Reserve; FedEx sinks after issuing its second warning about fiscal 2019 profit; Google's new cloud-based video-game playing and sharing platform, Stadia, will be powered by chips made by Advanced Micro Devices.
Global stocks were mixed Wednesday as investors awaited a key decision on interest rates and bond sales from the U.S. Federal Reserve and reacted to reports of potential tension in U.S.-China trade talks.
Company defends widely-used weed killer acquired in Monsanto deal last year.
U.S. stock futures tumble sharply as investors focus on slowing economic growth and simmering geopolitical tensions; Caterpillar, McDonald's, Verizon and 3M report earnings; Arconic is mulling an $11 billion offer from Apollo, a report says; a judge cuts the jury award against Bayer's Roundup.
Bayer shares fell sharply in Frankfurt Tuesday after a U.S. judge upheld a verdict that found weedkillers sold by its Monsanto franchise caused a California man's terminal cancer, but slashed the damage payout by nearly three quarters.
A California judge has slashed the punitive damages against Bayer in Roundup lawsuit.
San Francisco judge appears ready to overturn bulk of $289 million verdict against Bayer's Monsanto unit
U.S. stocks end near the day's lows amid concern Turkey's financial crisis could spread.
Turkey's lira fell to a fresh all-time low against the dollar overnight, extending its losses since July past 51%, as the country's economic crisis threatened to spillover into markets all over the world.
U.S. stock futures fall on Monday as Turkey's economic crisis escalates; Saudi Arabia's sovereign wealth fund is looking to invest in Tesla, a report says; Bayer plunges after subsidiary Monsanto loses 'Roundup' cancer trial.
Bayer fell the most in 15 years Monday after a California jury said its Monsanto subsidiary must pay former school groundskeeper Dewayne Johnson $289 million in damages for the cancer he contracted from the chemical group's 'Roundup' weedkiller.
Tech stocks are holding up stocks in Europe and pacing early gains for U.S. equity futures as yesterday's record close for the Nasdaq revives sector bulls amid ongoing concerns for global trade and growth.
In a Tuesday speech at the Boao Forum for Asia Chinese President Xi Jinping spoke of increasing imports, lowering foreign-ownership limits on manufacturing and expanding protection to intellectual property.
The FDA approved 11 different hematological treatments this year after approving 11 in the previous two years combined.
Bayer, which has agreed to buy U.S. seeds maker Monsanto, dipped more than 3% after cutting its outlook for drugs sales and warning of difficult times in U.S. consumer health.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.